TAYLOR GLEN A 4

What Happened
Glen A. Taylor (reported as a 10% owner; owner and chairman of Taylor Sports Group) purchased 18,750,000 Envoy Medical (COCH) shares on Feb 12, 2026 at $0.40 per share for a total cash outlay of $7,500,000. On the same date he also acquired two derivative positions totaling 30,000,000 shares at $0.00 (these represent Common Warrants/derivative securities rather than immediate-paid shares).

Key Details

• Transaction date: Feb 12, 2026; Form 4 filed Feb 17, 2026 (period of report: 2026-02-12).
• Cash purchase: 18,750,000 shares @ $0.40 = $7,500,000 (transaction code P = Purchase).
• Derivative acquisitions: 11,250,000 shares @ $0.00 and 18,750,000 shares @ $0.00 (transaction code P but reflect derivative/warrant issuance).
• Ownership after transaction: Not specified in the filing.
• Related parties: Filing notes the reporting person is owner/chairman of Taylor Sports Group (F1) and controls GAT Funding, LLC (F2).
• Warrant specifics: The acquired Common Warrants become exercisable upon the stockholder approval date (F3). Series A‑1 Warrants expire the earlier of 24 months after stockholder approval or 30 days after the company publicly announces submission of a PMA for its Acclaim cochlear implant (F4). Series A‑2 Warrants expire the earlier of 60 months after stockholder approval or 30 days after FDA approval for Acclaim (F5).

Context
This filing shows a meaningful cash purchase by a 10% owner (often more institutionally driven than routine executive trading) plus receipt of warrant/derivative securities that are contingent on future stockholder approval and regulatory milestones. The $7.5M cash purchase is the most concrete bullish signal in the report; the $0.00 entries reflect derivative instruments with exercise and expiration conditions rather than immediate-share purchases.